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ABSTRACT
RNA viruses encode an RNA-dependent RNA poly-
merase (RdRp) that catalyzes the synthesis of their
RNA(s). In the case of positive-stranded RNA viruses
belonging to the order Nidovirales, the RdRp resides
in a replicase subunit that is unusually large. Bioin-
formatics analysis of this non-structural protein has
now revealed a nidoviral signature domain (genetic
marker) that is N-terminally adjacent to the RdRp and
has no apparent homologs elsewhere. Based on its
conservation profile, this domain is proposed to have
nucleotidylation activity. We used recombinant non-
structural protein 9 of the arterivirus equine arteri-
tis virus (EAV) and different biochemical assays, in-
cluding irreversible labeling with a GTP analog fol-
lowed by a proteomics analysis, to demonstrate the
manganese-dependent covalent binding of guano-
sine and uridine phosphates to a lysine/histidine
residue. Most likely this was the invariant lysine of
the newly identified domain, named nidovirus RdRp-
associated nucleotidyltransferase (NiRAN), whose
substitution with alanine severely diminished the
described binding. Furthermore, this mutation crip-
pled EAV and prevented the replication of severe
acute respiratory syndrome coronavirus (SARS-CoV)
in cell culture, indicating that NiRAN is essential for
nidoviruses. Potential functions supported by NiRAN
may include nucleic acid ligation, mRNA capping and
protein-primed RNA synthesis, possibilities that re-
main to be explored in future studies.
INTRODUCTION
Positive-stranded (+) RNA viruses of the order Nidovirales
can infect either vertebrate (familiesArteriviridae andCoro-
naviridae) or invertebrate hosts (Mesoniviridae andRoniviri-
dae) (1,2). Examples of nidoviruses with high economic
and societal impact are the arterivirus porcine reproduc-
tive and respiratory syndrome virus (PRRSV) (3) and the
zoonotic coronaviruses (CoVs) causing severe acute respi-
ratory syndrome (SARS) and Middle East respiratory syn-
drome (MERS) in humans (4–6). While nidoviruses con-
stitute a monophyletic group, their genome size differences
are striking, with genomes ranging from 13–16 kb for ar-
teriviruses to 20–21 kb for mesoniviruses and 25–34 kb for
roniviruses and coronaviruses, which may reflect different
stages of the largest genome expansion known to have oc-
curred in RNA viruses (7).
Nidoviruses are characterized by their distinct poly-
cistronic genome organization, the conservation of key
replicative enzymes, and a common genome expression
and replication strategy (8) (Figure 1). Their distinctive
transcription mechanism involves the synthesis of a vari-
able set of subgenomic (sg) mRNAs, which are 3′ co-
terminal with the viral genome (reviewed in (9, 10)). In
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Figure 1. Genome organization and ORF1b-encoded enzymes and domains of nidoviruses. (A) The genome organization of Equine arteritis virus (EAV),
including replicase open reading frames (ORFs) 1a and 1b, and 3′ ORFs encoding structural proteins, is shown. Genomes of other nidoviruses employ
similar organizations while theymay vary in respect to size of different regions and number of 3′ ORFs. RFS, ribosomal frameshift site. (B) ORF1b size and
domain comparison between the five nidovirus (sub)families is shown for EAV (Arteriviridae), Cavally virus (CAVV,Mesoniviridae), Gill-associated virus
(GAV, Roniviridae), Breda virus (BRV-1, Torovirinae) and Severe acute respiratory syndrome coronavirus (SARS-CoV, Coronavirinae); see Supplementary
Table 1 for details regarding these viruses. NiRAN, nidovirus RdRp-associated nucleotidyltransferase; RdRp, RNA-dependent RNA polymerase; ZBD,
Zn-binding domain; HEL1, helicase superfamily 1 core domain; ExoN, exoribonuclease; N-MT, N7-methyltransferase; NendoU, nidovirus uridylate-
specific endoribonuclease; O-MT, 2′-O-methyltransferase; AsD, arterivirus-specific domain; RsD, ronivirus-specific domain. Depicted is a simplified do-
main organization sincemost enzymes are part ofmultidomain proteins.Note that viruses of theTorovirinae subfamily encode a truncated version ofN-MT.
Triangles, established cleavage sites by 3CLpro in two virus (sub)families; ORF1b-encoded proteins of other viruses may be proteolytically processed in a
similar way. The order of emergence of different nidovirus (sub)families is presented by a simplified tree on the left.
most nidoviruses, sg mRNAs and genome also share a
common 5′ leader sequence. The synthesis of sg mRNAs
(transcription) and genomeRNA (replication) is performed
by a poorly characterized replication-transcription com-
plex (RTC) that is comprised of multiple protein subunits
(reviewed in (11,12,13)) encoded in two large open read-
ing frames (ORFs), ORF1a and ORF1b, which are trans-
lated from the nidoviral genomic RNA (Figure 1A). The
two polyproteins (pp), pp1a and pp1ab, the latter resulting
from ribosomal frameshifting during genome translation,
are auto-catalytically processed by multiple cognate pro-
teases, one of which (the 3C-like (3CLpro) or main (Mpro)
protease) is responsible for the large majority of cleav-
ages (14). Downstream of ORF1b, nidovirus genomes con-
tain multiple smaller ORFs, known as the 3′ ORFs (7),
which are expressed from the sg mRNAs described above.
During evolution,most conserved proteins of nidoviruses
have diverged more extensively than those of organisms
of the Tree of Life. In line with the principal function of
each region, genome conservation increases from 3′ ORFs
to ORF1a to ORF1b (7). Accordingly, the 3′ ORF region
encodes virion proteins and, optionally, accessory proteins
that are predominantly group- or family-specific and medi-
ate virus–host interactions (15,16). ORF1a encodes a vari-
able number of proteins that include co-factors of theRNA-
dependent RNA polymerase (RdRp) and other ORF1b-
encoded enzymes, three hydrophobic proteinsmediating the
association of the RTC with membranes and the viral pro-
teases (13,17,18,19). The latter group includes the 3CLpro,
which is the only ORF1a-encoded enzyme conserved in all
nidoviruses. In contrast, ORF1b is highly conserved and
encodes different RNA-processing enzymes that critically
control viral RNA synthesis (Figure 1B). These invariantly
include the RdRp and a superfamily 1 helicase domain
(HEL1), which is fused with a multinuclear Zn-binding do-
main (ZBD). RdRp and HEL1 are expressed as part of two
different cleavage products residing next to each other in
pp1ab (8). The RdRp is believed to mediate the synthesis
of all viral RNA molecules, while over the years the un-
winding activity of the helicase was implicated in the control
of replication, transcription, translation, virion biogenesis,
and, most recently, post-transcriptional RNA quality con-
trol (reviewed in (20)). Among the lineage-specific proteins
encoded in ORF1b are four enzymes. A 3′-5′ exoribonucle-
ase (ExoN, in Coronaviridae, Mesoniviridae and Roniviri-
dae) and an N7-methyltransferase (N-MT, in the Coron-
avirinae subfamily, Mesoniviridae and Roniviridae) consti-
tute adjacent domains in the same pp1b cleavage prod-
uct. They were implicated in RNA proofreading (19,21–22)
and in 5′ end cap formation (23,24), respectively. Down-
stream of this subunit, nidoviruses encode an uridylate-
specific endoribonuclease of unknown function (NendoU,
in Arteriviridae and Coronaviridae) (25,26) and/or a 2′-O-
methyltransferase (O-MT) (inCoronaviridae,Mesoniviridae
and Roniviridae), which was implicated in 5′ end cap mod-
ification and immune evasion (23,27–29). All six ORF1b-
encoded enzymes have distantly related viral and/or cellular
homologs. Additionally, Roniviridae and Arteriviridae en-
code family-specific domains of unknown origin and func-
tion, RsD (30) and AsD (31,32), respectively.
The protein subunit containing the RdRp domain is
known as non-structural protein (nsp) 9 inArteriviridae and
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nsp12 in Coronaviridae (8). Its major ORF1b-encoded part
varies in size from ∼700 to ∼900 amino acid residues and
is N-terminally extended by a portion encoded in ORF1a.
The RdRp-containing replicase subunit of nidoviruses thus
seems to be larger than the characterized RdRps of other
RNA viruses, which commonly comprise less than 500
amino acid residues (33). RdRps adopt variations of an/
fold (reviewed in (34)) and have characteristic conserved se-
quences (motifs). In nidoviruses, these motifs were mapped
to the C-terminal one-third of the RdRp-containing pro-
tein (35,36), whose tertiary structure is available only as a
template-based model for SARS-CoV nsp12 (37,38).
With one notable exception (N-MT; 24), all ORF1b-
encoded enzymes were initially identified by comparative
genomic analysis involving viral and cellular proteins see
(31,39,13,36) and references there. These assignments were
fully corroborated by their subsequent biochemical charac-
terization (25–26,29,40–45). Furthermore, the (in)tolerance
to replacement of active site residues as tested in reverse
genetics studies of coronaviruses and arteriviruses in gen-
eral correlated well with the observed enzyme conserva-
tion. Accordingly, the replacement of conserved residues of
the nidovirus-wide conserved RdRp, ZBD and HEL1 were
lethal (46–48), while virus mutants were crippled upon in-
activation of ExoN, NendoU or O-MT enzymes (49–51),
which are conserved in only some of the nidovirus fami-
lies (30). This correlation is noteworthy since it coherently
links the results of the experimental characterization of a
few nidoviruses in cell culture systems to evolutionary pat-
terns that were shaped by natural selection in many hosts
over an extremely large time frame. The fact that this cor-
relation is evident for nidoviruses overall, rather than for
separate families, indicates that nidovirus-wide comparative
genomics provides sensiblemodels to the functional charac-
terization of the most conserved replicative proteins.
In the present study, we aimed to elucidate the domain
organization, origin and function of the RdRp-containing
proteins of nidoviruses by integrating bioinformatics, bio-
chemistry and reverse genetics in a manner that was val-
idated in many prior studies. Our extensive bioinformat-
ics analysis revealed a novel domain, encoded upstream of
the RdRp domain within the same cleavage product. It is
conserved in all nidoviruses and has no apparent viral or
cellular homologs, making it a second genetic marker for
the orderNidovirales. Based on results obtained using EAV
and SARS-CoV, this domain was concluded to have an es-
sential nucleotidylation activity and was named nidovirus
RdRp-associated nucleotidyltransferase (NiRAN). Its po-
tential functions in nidovirus replication may include RNA
ligation, protein-primed RNA synthesis, and the guanylyl-
transferase function that is necessary for mRNA capping.
MATERIALS AND METHODS
Virus genomes
Genomes of nidoviruses were retrieved from GenBank (52)
and RefSeq (53) using Homology-Annotation hYbrid re-
trieval of GENetic Sequences (HAYGENS) tool http://
veb.lumc.nl/HAYGENS. Genomes of all viruses were used
to produce sequence alignments (see below), which were
purged to retain only subsets of viruses representing the
known diversity of each nidovirus family for downstream
bioinformatics analyses. For the Arteriviridae and Coron-
aviridae families, one representative was drawn randomly
from each evolutionary compact cluster corresponding to
known and tentative species that were defined with the
help of DEmARC1.3 (54). Twenty nine viruses of the fam-
ily Mesoniviridae were clustered into six groups, whose
intra- and inter-group evolutionary distance was below and
above 0.075, respectively. One representative was chosen
randomly from each of the six groups. For the Roniviridae
family, two viruses, each prototyping a species, were used.
To retrieve information about genomes, the SNADprogram
(55) was used. The final subsets include 30, 5, 10, 6 and 2
sequences representing all established and putative taxa of
corona-, toro-, arteri-, mesoni- and roniviruses, respectively
(Supplementary Table S1).
Multiple sequence alignments and secondary structure pre-
diction
Multiple sequence alignments (MSAs) of proteins were gen-
erated using the Viralis platform (56) and assisted by HM-
MER 3.1 (57), Muscle 3.8.31 (58) and ClustalW 2.012
(59) programs in default modes. We have produced family-
wide MSAs of nsp12 of coronaviruses, nsp9 of arteriviruses
and their counterparts of mesoniviruses and roniviruses,
whose borders have been tentatively mapped through lim-
ited similarity with known 3CLpro cleavage sites of these
viruses (60,61). They included NiRAN and RdRp do-
mains delineated as described separately. For simplicity,
we will refer to the proteins of mesoni- and roniviruses
as nsp12t, with ‘t’ standing for tentative, since the pro-
teolytic cleavage of the replicase polyproteins of these
viruses remains to be addressed in detail. Besides NiRAN
and RdRp, we have also produced family-specific MSAs
of three other nidovirus-wide conserved protein domains:
3CLpro, HEL1 and ZBD. Family-specific MSAs of the Ni-
RAN domain were combined in a stepwise manner us-
ing the profile mode of ClustalW with subsequent man-
ual local refinement, which was limited and guided by re-
sults obtained using HHalign of the HH-suite 2.0.15 soft-
ware (62,63) when and if the two programs disagreed.
The produced MSAs included one, two, three, four and
five (sub)families, respectively, namely: Coronavirinae and
Torovirinae (named CoTo), Coronaviridae and Mesoniviri-
dae (CoToMe), Coronaviridae,Mesoniviridae and Roniviri-
dae (CoToMeRo), Coronaviridae, Mesoniviridae, Roniviri-
dae and Arteriviridae (CoToMeRoAr). The final MSA of
NiRAN is presented in Supplementary Figure S1 in an an-
notated format and Supplementary Table S2 in FASTA for-
mat.
To reveal all local similarities between two MSAs, their
profiles were compared using an align routine in HH-suite
2.0.15, whose results were visualized in a dot-plot fashion
with the -dthr = 0.25 and -dwin = 10. Statistical signif-
icance of similarity was measured using % of confidence
and expectation value (E). HH-suite calculates those for the
best local hit in an MSA, regardless whether the latter was
produced using the local or global mode of the program.
Consequently, similarity of global MSAs may be underes-
timated. Based on family-specific MSAs of NiRAN and
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RdRp, the secondary structure of these domains was pre-
dicted using software Jpred 3 (64) and PSIPRED (65). In
both cases, the sequence with the least gaps was selected
from the sequences forming the MSA. The prediction was
made only for columns of the MSA in which the selected
sequence does not contain gaps. The MSAs were converted
into the final figure using ESPript (66).
Homology detection in protein databases
The obtained MSAs were converted into Hidden Markov
Model (HMM) profiles or position-specific scoring matri-
ces (PSSM) and used as queries to search for homologs in
three different types of databases composed of: individual
sequences (nr database, including GenBank CDS transla-
tions, RefSeq proteins, SwissProt, PIR and PRF (67)), pro-
files (PFAMA (68)), and protein 3D structures (PDB (69)).
For GenBank scanning, HMMER 3.1 software (57) was
used with the E-value cutoff of 10. To search for homologs
among protein profiles and 3D structures, HHsearch of
HH-suite 2.0.15 software (62,63) and pGenTHREADER
8.9 software (70–72) were used, respectively.
In comparisons with the PDB (www.rcsb.org, (69)) us-
ing pGenTHREADER, RdRps of different viruses domi-
nated the hit list for the best sampled nidoviruses, corona-
and arteriviruses, and they were consistently present among
the top hits for the two other families. Typically the simi-
larity between a nidovirus query and a target encompassed
the entire target and was limited to the C-terminal part
of the query, with the N-terminal ∼250 and 350 amino
acid residues remaining unmatched in arteriviruses and
other nidoviruses, respectively (Figure 2A). Likewise, the
C-terminal part of nsp9/nsp12/nsp12t matched the RdRp
profiles of different virus families in PFAM (68) and an in-
house database although this analysis was complicated by
the presence of nidovirus sequences in the top-hit PFAM
profile (see below). Based on these results we concluded that
nsp9, nsp12 and nsp12t contain N-terminal domains that
are not part of canonical RdRps. This domain is referred to
as NiRAN in this manuscript.
Evolutionary analyses
To estimate the divergence of NiRAN and RdRp, two anal-
yses were conducted. Distribution of similarity density in
MSAs of NiRAN and RdRp was plotted using R pack-
age Bio3D (73) under the conservation assessment method
‘similarity’, substitution matrix Blosum62 (74) and a slid-
ing window of 11 MSA columns. Peaks of similarity were
attributed to the known RdRp motifs G, F, A, B, C, D, E
(35), or named and assigned to the newly recognized mo-
tifs of NiRAN, preA, A, B and C. Suffix R and N were
added to motif labels of the RdRp and NiRAN domain, re-
spectively. Reconstruction of phylogenetic trees of NiRAN
and RdRp of different (sub)families was performed using
PhyML 3.0, with the WAG amino acid substitution ma-
trix, allowing substitution rate heterogeneity among sites
(eight categories) and 1000 iterations of non-parametric
bootstrapping (75). Pairwise patristic distances (PPDs) be-
tween viruses were calculated from these trees usingR pack-
age ‘ape’ (76). They were used to assess relative rates of evo-
lution of NiRAN and RdRp domains through the compar-
ison of linear regressions, which were fit into the respective
PPD distributions as implemented in R package ‘stats’ (77).
Protein expression and purification
Nucleotides 5256 to 7333 of the genome of the EAV
Bucyrus strain were cloned into a pASK3 (IBA) vector es-
sentially as described (47) to yield a construct that expresses
nsp9 that is N-terminally fused to ubiquitin and taggedwith
hexahistidine at its C-terminus. Mutations were introduced
according to the QuikChange protocol and verified by se-
quencing. Plasmids were transformed into Escherichia coli
C2523/pCG1, which constitutively express the Ubp1 pro-
tease to remove the ubiquitin tag during expression and
thereby generate the native nsp9 N-terminus. Cells were
cultured in Luria Broth in the presence of ampicillin (100
g/ml) and chloramphenicol (34 g/ml) at 37◦C until an
OD600 >0.7. At this point protein expression was induced
by the addition of anhydrotetracycline to a final concentra-
tion of 200 ng/ml and incubation was continued at 20◦C
overnight. Cell pellets were harvested by centrifugation and
stored at −20◦C until further use.
Proteins were batch purified by immobilized metal ion
affinity chromatography using Co2+ Talon beads. In short,
cell pellets were resuspended in lysis buffer (20mMHEPES,
pH 7.5, 10% glycerol (v/v), 10 mM imidazole, 5 mM -
mercaptoethanol) supplemented with 500 mM NaCl. Ly-
sis was achieved by a 30-min incubation with 0.1 mg/ml
lysozyme and five subsequent cycles of 10-s sonication to
shear genomic DNA. Cellular debris was removed by cen-
trifugation at 20 000 g for 20 min. The cleared supernatant
was recovered and equilibrated Talon-beads were added.
After 1 h of binding under agitation, beads were washed
four times for 15 min with a 25-times bigger volume of lysis
buffer containing first 500 mM, than 250 mM, and finally
twice 100 mMNaCl. In the end, proteins were eluted twice
with lysis buffer containing 100 mM NaCl and 150 mM
imidazole. Both fractions were pooled and dialyzed twice
for 6 h or longer against an at least 100-fold bigger volume
of 20 mM HEPES, pH 7.5, 50% glycerol (v/v), 100 mM
NaCl, 2 mM DTT. All steps of the purification were per-
formed at 4◦C or on ice. All mutant proteins were expressed
and purified in parallel with the wild-type protein used as
reference in nucleotidylation assays. Protein concentrations
were measured by absorbance at 280 nm using a calculated
extinction coefficient of 93 170 M−1cm−1 and a molecular
mass of 77 885Da for wild-type nsp9. Typical protein yields
were 5 mg/l culture and nucleotidylation activity was ob-
served for at least 4 months if stored at −20◦C at a concen-
tration below 15M.Finally, the absence of theN-terminal
ubiquitin tag was confirmed by mass spectrometry.
Nucleotidylation assay
Nucleotidylation assayswere performed in a total volume of
10l containing, unless specified otherwise, 50mMTris, pH
8.5, 6 mMMnCl2, 5 mMDTT, up to 2.5 Mnsp9 and 0.17
M [-32P]NTP (Perkin Elmer, 3000 Ci/mmol). Further-
more, 12.5% glycerol (v/v), 25 mM NaCl, 5 mM HEPES,
pH7.5, and 0.5mMDTTwere carried over from the protein
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Figure 2. Delineation and divergence of the NiRAN domain in the RdRp-containing proteins of nidoviruses. (A) Sequence variation, domain organization
and secondary structure of the RdRp-containing protein of arteriviruses, and location of peptides identified by mass spectrometry after FSBG-labeling
of arterivirus nsp9. Shown is the similarity density plot obtained for the multiple sequence alignment (MSA) of proteins including NiRAN and RdRp
domains of arteriviruses. To highlight the regional deviation of conservation from that of the MSA average, areas above and below the mean similarity
are shaded in black and grey, respectively. Uncertainty in respect to the domain boundary between NiRAN and RdRp is indicated by a dashed horizontal
line. Positions of conserved sequence motifs of NiRAN and RdRp are indicated by vertical shading areas; motifs are labeled. Below the similarity density
plot, secondary structure elements, predicted based on the arterivirus MSA using PSIPRED (PSIPRED A) and Jpred 3 (JPRED A), are presented in grey
for -helices, black for -strands. (B) Relative scale of divergence of NiRAN versus RdRp in four different nidovirus (sub)families. Shown is scatter plot
of PPDs of the NiRAN (y-axis) versus PPDs of RdRp (x-axis), which were calculated from the respective four PhyML trees. Dashed lines depict linear
regressions fit in four differently highlighted PPD distributions, with its detail being magnified in the zoom-in; R2 and slope values of the regressions are
listed in the inset panel. The solid diagonal line corresponds to the matching rate of PPDs for the two domains and is provided for comparison. (C) MSA of
the three conserved NiRANmotifs of eight representative nidoviruses and their predicted secondary structures. Absolutely conserved residues are in white
font, while partially conserved residues are highlighted. Secondary structure predictions weremade with PSIPRED (64) based on arterivirus (PSIPRED A)
or coronavirus (PSIPRED C) MSAs. Residues mutated in recombinant SARS-CoV (Coronaviridae) non-structural protein (nsp) 12 and recombinant EAV
(Arteriviridae) nsp9 are indicated by filled (conserved) and empty (control) circles, above and below the alignment respectively. Mutated residues D445A
in EAV and K103A, D618A in SARS-CoV are not shown. Amino acid numbers above and below the alignment refer to SARS-CoV nsp12 and EAV nsp9,
respectively.MERS-CoV,Middle East respiratory syndrome coronavirus (Coronaviridae); GAV (Roniviridae); YHV, yellow head virus (Roniviridae); CAVV
(Mesoniviridae); MenoV,Meno virus (Mesoniviridae); PRRSV-1, porcine reproductive and respiratory syndrome virus, European genotype (Arteriviridae).
For other abbreviations, see Figure 1.
storage buffer. In preliminary experiments magnesium (1–
20 mM) did not support nucleotidylation activity and was
consequently not pursued further. Samples were incubated
for 30 min at 30◦C. Reactions were stopped by addition of 5
l gel loading buffer (62.5mMTris, pH 6.8, 100mMdithio-
threitol (DTT), 2.5% sodium dodecyl sulphate (SDS), 10%
glycerol, 0.005% bromophenol blue) and denaturing of the
proteins by heating at 95◦C for 5 min. 12% sodium dodecyl
sulphate-polyacrylamide gel electrophoresis (SDS-PAGE)
gels were run, stainedwithCoomassieG-250, and destained
overnight. After drying, phosphorimager screens were ex-
posed to gels for 5 h and scanned on a Typhoon variable
mode scanner (GE healthcare), after which band intensities
were analyzed with ImageQuant TL software (GE health-
care). The buffers used to find the pH optimum of the nu-
cleotidylation reaction wereMES (pH 5.5–6.5), MOPS (pH
7.0), Tris (pH 7.5–8.5) and CHES (pH 9.0–9.5) (20 mM).
To assess the chemical nature of the nucleotide-protein
bond, the pH was temporarily shifted after product forma-
tion. To this end, 1 l HCl or NaOH (both 1 M) was added
before incubation at 95◦C for 4 min. Afterward the origi-
nal pHwas restored by addition of the complementary base
or acid, and samples were separated and analyzed as de-
scribed.
FSBG labeling and mass spectrometry
Reaction mixtures were the same as described for the
nucleotidylation assay with two modifications: radioac-
tive nucleotides were replaced by up to 2 mM of the
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reactive guanosine-5’-triphosphate (GTP) analog 5′-(4-
fluorosulfonylbenzoyl)guanosine (FSBG) (78), of which
the synthesis is described in supplementary Materials and
Methods, and samples were incubated for 1 h at 30◦C to
increase the ratio between labeled and unlabeled protein.
Subsequently, the protein (20 g) was reduced by addition
of 5 mM DTT and denatured in 1% SDS for 10 min at
70◦C. Next, the samples were alkylated by addition of 15
mM iodoacetamide and incubation for 20 min at RT. Next,
the protein was applied to a centrifugal filter (Millipore
Microcon, MWCO 30 kDa) and washed three times with
NH4HCO3 (25 mM) before a protease digestion was per-
formed with 2 g trypsin in 100 l NH4HCO3 overnight at
RT. Recovered peptides were treated with 50mMNaOH for
25 min, desalted using Oasis spin columns (Waters) and fi-
nally analyzed by on-line nano-liquid chromatography tan-
dem mass spectrometry on an LTQ-FT Ultra (Thermo,
Bremen, Germany). Tandem mass spectra were searched
against the Uniprot database, using mascot version 2.2.04,
with a precursor accuracy of 2 ppm and product ion accu-
racy of 0.5 Da. Carbamidomethyl was set as a fixed modi-
fication, and oxidation, N-acetylation (protein N-terminus)
and FSBG were set as variable modifications.
Label release
For analysis of the released nucleotides, 350 pmol of
nsp9 were nucleotidylated with [-32P]nucleoside-5’-
triphosphates ([-32P]NTPs) as described above for 1 h at
30◦C. After the reaction free NTPs were removed by buffer
exchange and extensive washing with the help of a centrifu-
gal filter (Millipore ultrafree-0.5, MWCO 10 kDa). Protein
was precipitated with a five times greater volume of acetone
overnight at−20◦C. The resulting pellet was resuspended in
20 mM Tris, pH 8.5, 100 mM NaCl. Equal amounts of the
solutions were incubated at 95◦C for 4 min after addition
of HCl or NaOH (1 M). Samples were adjusted to their
original pH and spotted onto polyethylenimine cellulose
thin layer chromatography plates, which were developed
in 80% acetic acid (1 M), 20% ethanol (v/v), 0.5 M LiCl.
Plates were dried and phosphorimaging was performed
as described above. Non-radioactive nucleotide standards
were run on each plate and visualized by UV-shadowing to
allow the identification of the radioactive products.
Reverse genetics of EAV
Alanine-coding mutations for conserved and control
residues were introduced into full-length cDNA clone
pEAV211 (79) using appropriate shuttle vectors and restric-
tion enzymes. The presence of the mutations was confirmed
by sequencing. pEAVplasmidDNAwas in vitro transcribed
with the mMessage-mMachine T7 kit (Ambion), and the
synthesized RNA was transfected into BHK-21 cells after
LiCl precipitation as described previously (80). Virus repli-
cation was monitored by immunofluorescence microscopy
until 72 h post transfection (p.t.) using antibodies directed
against nsp3 and N protein as described (81) and by plaque
assays (80) using transfected cell culture supernatants, to
monitor the production of viral progeny.
Sequence analysis of the nsp9-coding region was per-
formed to either verify the presence of the introducedmuta-
tions or to monitor the presence of (second site) reversions.
For this purpose, fresh BHK-21 cells were infected with
virus-containing cell culture supernatants and total RNA
was extracted with Tripure Isolation Reagent (Roche Ap-
plied Science) after appearance of cytopathic effect (CPE)
(typically at 18 h post infection (p.i.)). EAV-specific primers
were used to reverse transcribe RNA and PCR amplify the
nsp9-coding region (nt 5256–7333). RT-PCR fragments of
the EAV genome were sequenced after gel purification and
sequences compared to those of the respective RNA used
for transfection.
Reverse genetics of SARS-CoV
Mutations in the SARS-CoV nsp12-coding region were en-
gineered in prSCV, a pBeloBac11 derivative containing a
full-length cDNA copy of the SARS-CoV Frankfurt-1 se-
quence (82) by using ‘en passant recombineering’ as de-
scribed in Tischer et al. (83). The (mutated) BACDNAwas
linearized with NotI, extracted with phenol–chloroform,
and transcribed with T7 RNA Polymerase (mMessage-
mMachine T7 kit; Ambion) using an input of 2 g of BAC
DNA per 20-l reaction. Viral RNA transcripts were pre-
cipitated with LiCl according to the manufacturer’s proto-
col. Subsequently, 6 g of RNA were electroporated into 5
× 106 BHK-Tet-SARS-N cells, which expressed the SARS-
CoV N protein following 4 h induction with 2 M doxy-
cycline as described previously (84). Electroporated BHK-
Tet-SARS-N cells were seeded in a 1:1 ratio with Vero-E6
cells. Viral protein expression and the production of vi-
ral progeny was followed until 72 h p.t. by immunofluo-
rescence microscopy using antibodies directed against nsp4
and N protein and by plaque assays of cell culture super-
natants, respectively (both methods were described previ-
ously in Subissi et al. (84)). All work with live SARS-CoV
was performed inside biosafety cabinets in a biosafety level
3 facility at Leiden University Medical Center.
For sequence analysis of viral progeny, fresh Vero-E6
cells were infected with harvests from viable mutants taken
at 72 h p.t., and SARS-CoV RNA was isolated 18 h p.i.
using TriPure Isolation Reagent (Roche Applied Science)
as described in the manufacturer’s instructions. Random
hexamers were used to prime the RT reaction, which was
followed by amplification of the nsp12-coding region (nt
13398–16166) by using SARS-CoV-specific primers. RT-
PCR products were sequenced to verify the presence of the
introduced mutations.
RESULTS
Delineation of a novel, unique domain that is conserved up-
stream of the RdRp in polyproteins of all nidoviruses
Inspection of the intra-family sequence conservation for
(sub)family-specific MSAs of nsp9, nsp12 and nsp12t (see
‘Materials and Methods’ section for technical details) us-
ing density similarity plots (Supplementary Figure S2) con-
firmed the association of characteristic RdRp motifs with
some of the most prominent conservation peaks, located in
the C-terminal half of nsp9 and nsp12 (RdRp domain). For
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nsp12t, similar conclusions could be drawn although the
conservation profiles of these viruses, especially roniviruses,
were of lesser resolution due to the overall higher similarity
that was the result of the limited virus sampling and diver-
gence. Importantly, also the N-terminal half of nsp9 and
nsp12 (NiRAN domain) included a few above-average con-
servation peaks although the overall conservation was ev-
idently highest around the established RdRp motifs (Fig-
ure 2A; Supplementary Figure S2). Likewise, NiRAN com-
pared to RdRp accepted two–to-three times more sub-
stitutions in four nidovirus (sub)families (Figure 2B). In
this comparison, slopes of the four PPD distributions were
strikingly similar, particularly in the pairs of theCoronaviri-
nae and Torovirinae (60.6 and 60.5, respectively) and the
Mesoniviridae and Arteriviridae (67.9 and 68.1). Thus, Ni-
RAN must have evolved under similar constraints in dif-
ferent lineages of nidoviruses, which is compatible with a
common function of this domain.
Next, we investigated the relation of the NiRAN do-
mains of the four different families by pairwise profile–
profile comparisons using HHalign in local mode (see Sup-
plementaryFigure S3 andFigure 3 for all results and a selec-
tion of thereof, respectively). This analysis revealed strong
support (∼98% confidence andE= 7.7e-09–1.7e-08) for the
similarity betweenNiRANsof coronavirus/torovirus nsp12
and mesonivirus nsp12t, and moderate support (∼21–30%
confidence and E = 0.00051–0.00091) for the similarity be-
tween the respective domains of mesoni- and roniviruses.
Based on these observations, we have aligned the NiRAN
domain of coronavirus nsp12 andmesonivirus nsp12t using
the profile mode of ClustalW, with the MSA being slightly
adjusted taking into account the HHalign-mediated results.
This MSA of two families was superior compared to each
of the two family-specific MSAs with respect to its similar-
ity to the MSA of roniviruses (∼54–75% confidence and E
= 0.00011–0.00049). Consequently, the ronivirus MSA was
added to the MSA of corona/toro- and mesoniviruses to
generate anMSA of the NiRAN of the three families, here-
after called ExoN-encoding nidoviruses with reference to
the domain that distinguishes this group from arteriviruses
(Figure 1B). In the above HHsearch local alignments, al-
most the full-length NiRAN domains were aligned.
In contrast to the above observations, the support for
similarity between the NiRAN MSAs of arteriviruses and
ExoN-encoding nidoviruses, separately or combined, in our
HHalign-based analysis was relatively weak (E= 0.03–0.4),
particularlywith respect to confidence (1.5%orworse). This
could be due to the similarity being recognized only in a
small C-terminal region. This experience prompted us to
compare conserved motifs and predicted secondary struc-
tures of the domains of these families (Supplementary Fig-
ures S1 and S2). Ten residues were found to be invariant in
the conserved NiRAN of the ExoN-encoding nidoviruses.
They map to three motifs designated AN (with a K-x[6–9]-
E pattern in ExoN-encoding nidoviruses), BN (R-x[8–9]-D)
andCN (T-x-DN-x4-G-x[2,4]-DF), respectively, withmotifs
BN and CN representing the most prominent conservation
peaks of this domain in coronaviruses (Supplementary Fig-
ure S2). Remarkably, similar conserved motifs are present
in the NiRAN of arteriviruses (Figure 2A and C), where
BN and CN again occupy the two most prominent peaks
(Supplementary Figure S2). The three motifs are similarly
positioned relative to the ORF1a/ORF1b frameshift sig-
nal in all nidoviruses, and, importantly, they were aligned
in arteriviruses and the ExoN-encoding nidoviruses using
HHalign in global mode (Figure 3, rightmost plot). Specif-
ically, all four invariant residues of motifs AN and BN
of ExoN-encoding nidoviruses are also conserved in ar-
teriviruses although with slightly smaller distances sepa-
rating the two residues of each pair (Supplementary Fig-
ure S1 and Figure 2C). In the most highly conserved mo-
tif CN, the aspartate-phenylalanine dipeptide and likely
glycine (the only deviating arginine at this position in the
lactate dehydrogenase-elevating virus isolate U15146 may
result from a sequencing error) are absolutely conserved
among nidoviruses while the other invariant residues of
ExoN-encoding nidoviruses appear to have been replaced
by similar residues in arteriviruses. Additionally, there is
a good agreement between the predicted secondary struc-
ture for the domains of arteriviruses and ExoN-encoding
nidoviruses, particularly in the area encompassing the three
sequence motifs as well as regions immediately upstream
of motif AN (named preAN motif) and downstream of
motif CN (Supplementary Figure S1). In ExoN-encoding
nidoviruses, motifs BN and CN are separated by a variable
region of 40–60 amino acid residues that does not include
absolutely conserved residues, while in arteriviruses motifs
BN and CN are adjacent. Based on these observations, we
concluded that nsp9, nsp12 and nsp12t contain the NiRAN
domain, which is conserved in all nidoviruses, although we
acknowledge that the support for the conservation of differ-
ent motifs between different nidovirus (sub)families is not
equally strong. Also, we noted that, at this stage, it was not
possible to precisely define the C-terminal border of the Ni-
RAN domain. NiIRAN and RdRp may thus, be adjacent
or separated by another small domain of variable size in dif-
ferent nidoviruses (Supplementary Figure S2).
To gain insight into the origin and function of the Ni-
RANdomain, we comparedMSA-based profiles of this do-
main and its individual motifs of different nidovirus fam-
ilies and the entire order with the PFAM, GenBank, Vi-
ralis DB and PDB databases. As a control, we used the
HMM profiles of four other domains that are conserved
in all nidoviruses, 3CLpro, RdRp, ZBD and HEL1. We ex-
pected to find hits to either other nidovirus proteins, if Ni-
RAN would have emerged by duplication or non-nidovirus
proteins, if the NiRAN ancestor would have been acquired
from an external source. None of the database scans involv-
ing theNiRAN retrieved a non-nidovirus hit whoseE-value
was better than 0.065 for HMMER and 1.3 for the HH-
search program fromHH-suite (Figure 4) and none of these
hits had sequences similar to the motifs of the NiRAN. In
contrast, statistically significant hits with virus and/or host
proteins were identified for the nidoviral control proteins ei-
ther in both or one of the scans; according to annotation, at
least some of these hits were true positives in the functional
and/or structural sense. Likewise, in scans of the PDB using
pGenTHREADER, all top hits for the NiRAN of the four
virus families had low support (P = 0.014 or worse) with
no match of the conserved motifs. In contrast, top hits for
four RdRp queries were supported with P-values of 0.0003
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Figure 3. Establishing sequence conservation between NiRAN domains of different (sub)families. Shown are four pairwise dot-plots that compare HMM
profiles of NiRAN domains of different origins using HHalign. For the entire set of dot-plots generated, please see Supplementary Figure S3. The bottom
three plots correspond to steps used to produce the nidovirus-wide NiRANMSA (Supplementary Figure S1), while the top plot is shown for comparison.
Coordinates of query and target HMMs are presented on y-axis and x-axis, respectively. All local similarities between two profiles are depicted as black dots.
Transparent fat dark and light gray lines on the dot-plot show paths of HHalign alignments, obtained in local and global modes, respectively. The E-value
of the top local alignment is specified below each dot-plot. In the profile–profile alignment produced in global mode, conserved amino acids of NiRAN
motifs may have been properly aligned or not. If conserved residues of a motif were aligned, the corresponding region of the alignment path is labeled
with the respective motif name without an asterisk. If the misalignment of conserved residues was limited to a shift of one or two residues (HMM–HMM
alignment columns), the corresponding region of the alignment path is labeled with the respective motif name plus an asterisk.
Figure 4. Comparison of nidovirus-wide conserved domains with sequence databases. Shown are histograms depicting E-values of the best non-nidovirus
hits obtained duringHMMER-mediated profile-sequence (A) andHHsearch-mediated profile–profile (B) searches of theGenBank andPFAMAdatabases,
respectively, using MSA profiles of five nidovirus-wide conserved domains encoded by four nidovirus families. The identity of the non-nidoviral top-hit
in the respective databases is specified. Stars indicate hits whose homologous relationship with the respective query is also supported by the functional
and/or structural annotation of the respective targets.
or better and targeted RdRps of other viruses, at least for
arteri- and coronavirus queries.
EAV nsp9 hasMn2+-dependent nucleotidylation activity with
UTP/GTP preference
Since we could not identify any homologs of the NiRAN
domain whose prior characterization would facilitate the
formulation of a hypothesis about its function, we have re-
viewed the available information about nidovirus genome
organization and replicative enzymes, and the results de-
scribed above. The data were most compatible with the hy-
pothesis that this domain is an RNA processing enzyme,
in view of (i) the abundance of RNA processing enzymes
in the ORF1b-encoded polyprotein (Figure 1B); and (ii)
the profile of invariant residues, composed of aspartate,
glutamate, lysine, arginine and phenylalanine (and possibly
glycine) (Figure 2C), the first four of which are among the
most frequently employed catalytic residues (85). Since the
domain is uniquely conserved in nidoviruses, we hypothe-
sized that its activity might work in concert with that of
another, similarly unique RNA processing enzyme. At the
time of this consideration, the NendoU endoribonuclease
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of nidoviruses was believed to be such an enzyme (25) (as-
sessment revised in 2011, (30)). Consequently, we reasoned
that a ligase function would be a natural counterpart for the
endoribonuclease (NendoU), as observed in many biologi-
cal processes, and would fit in the functional cooperation
framework outlined in our previous analysis of the SARS-
CoV proteome (39). This hypothesis was also compatible
with the predicted / structural organization of NiRAN
(Supplementary Figure S1) and the lack of detectable sim-
ilarity between NiRAN and the highly diverse nucleotidyl-
transferase superfamily, to which nucleic acid ligases be-
long. This superfamily is known to include groups that dif-
fer even in the most conserved sequence motifs, especially
in proteins of viral origin (86,87). Based on mechanistic in-
sights obtained with other ligases, we expected that the con-
served lysine might be the principal catalytic residue of the
NiRAN domain.
To detect this putative NTP-dependent RNA ligase ac-
tivity, we took advantage of the universal ligase mechanism,
which can be separated into three steps (88). First, an NTP
molecule, typically adenosine triphosphate (ATP), is bound
to the enzyme’s binding pocket, and a covalent bond is es-
tablished between the nucleotide’s -phosphate, nucleoside-
5’-monophosphate (NMP) and the side chain of either ly-
sine or histidine, while pyrophosphate is released. Since this
protein–NMP is a true, temporarily stable intermediate, it
can be readily detected by biochemical methods. In con-
trast, demonstration of the following two steps, NMP trans-
fer to the 5′ phosphate of anRNA substrate and subsequent
ligation of a second RNA molecule under release of the
NMP, depends on the availability of target RNA sequences
whose identification is often not as straightforward. Thus,
we first assessed our hypothesis by testing the covalent bind-
ing of a nucleotide, known as nucleotidylation.
To this end, recombinant EAV nsp9 was expressed in E.
coli, purified, and incubated with each of the four NTPs,
which were 32P-labeled at the -position. Samples were ana-
lyzed using denaturing SDS-PAGE to discriminate between
covalent and affinity-based nucleotide binding. As can be
seen in Figure 5A, we could indeed detect a radioactively
labeled product with a mobility comparable to that of nsp9
in the presence of GTP and uridine-5’-triphosphate (UTP).
To verify that this labeled band corresponded to a protein
and did not result from 3′ end labeling of co-purified E. coli
RNA or polyG synthesis by the RNA polymerase residing
in the C-terminal domain of nsp9, guanylylation was fol-
lowed by the addition of either proteinase K or RNase T1,
which cleaves single-stranded RNA after G residues. As ex-
pected, only protease treatment removed the band while in-
cubation with RNase T1 had no effect on the product (Fig-
ure 5B). The same result was obtained after uridylylation
using RNase A, which cleaves after pyrimidines in single-
strandedRNA (data not shown). Furthermore, as the use of
GTP labeled in the  -position did not result in a radioactive
product, we conclude that this phosphate, in agreementwith
the general nucleotidylation mechanism, is released during
the reaction (Figure 5B).
Unexpectedly, we observed amarked substrate specificity
of nsp9 for UTP, which resulted in the accumulation of five
times more enzyme–nucleotide complex than observed with
GTP. In contrast, we observed no covalent binding with
Figure 5. EAV nsp9 has nucleotidylation activity. Purified recombinant
EAV nsp9 (78 kDa) was incubated with the indicated 32P-labeled NTP
in the presence of MnCl2. After denaturing SDS-PAGE, reaction prod-
ucts were visualized by Coomassie brilliant blue staining (top panels) and
phosphor imaging (bottom panels). Positions of molecular weight mark-
ers are depicted on the left in kDa. (A) Uridylylation and guanylylation
activity as revealed by covalent binding of the respective radioactive nu-
cleotide to nsp9. Note that the protein indicated with an asterisk likely
is an Escherichia coli-derived impurity reacting with ATP. Relative band
intensities are shown at the bottom. (B) Guanylylation was distinguished
from RNA polymerization by incubating the products generated during
the nucleotidylation assay with proteinase K (1 mg/ml) or with RNase T1
(0.5 U), which cleaves single-stranded RNA after G residues, for 30 min at
37◦C.
ATP or cytidine-5’-triphosphate (CTP) as substrates (Fig-
ure 5A). The observed substrate preferences are remark-
able for two reasons. First, since both UTP and GTP are
present in significantly lower concentrations under physi-
ological conditions than ATP (89) and are in general not
used as primary energy source, it suggests that the iden-
tity of the base, rather than the energy stored within the
phosphodiester bonds, may be critical for a subsequent step
in the reaction pathway. This implies that reaction path-
ways other than RNA ligation, which predominantly uti-
lizes ATP, must be considered. Second, the selective utiliza-
tion of only one pyrimidine and one purine substrate raised
questions about the nature and number of active sites in-
volved, for instance, whether both nucleotides bind to sepa-
rate binding sites or utilize different catalytic residueswithin
the same binding site. Unfortunately, there are no crystal
structures for any of the nidovirus nsp9/nsp12/nsp12t sub-
units available to date, which might have been used to re-
solve this matter in docking studies.
To characterize the NTP binding further, we compared
the pH dependence of both activities. Interestingly, while
the relative activities below pH 8.5 were identical with both
substrates, the relative guanylylation activity was exceed-
ingly higher than uridylylation at a pH above 8.5 (Fig-
ure 6A). To exclude that the observed pattern is due to a
difference in the metal ion requirement, we determined the
optimal manganese concentration for nucleotidylation with
both substrates. As is apparent from Figure 6B, both activ-
ities share the same broad optimum between 6 and 10 mM
MnCl2. This result made it unlikely that manganese oxida-
tion and a concomitant decrease of available Mn2+ ions, as
we observed at a pH above 9.0, would selectively favour the
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Figure 6. EAV nsp9 guanylylation has a slightly broader or shifted pH optimum compared to uridylylation while the metal ion requirement is identical. (A)
The pH optimum in the range from 5.5 to 9.5 was determined using the buffers listed in ‘Materials and Methods’ section. (B) Assessment of the optimal
MnCl2 concentration for nucleotidylation. Error bars represent the standard deviation of the mean based on three independent experiments.
utilization of one of the two substrates. The observed differ-
ence between guanylylation and uridylylation with regard
to its pH optimum may thus be genuine. For instance, this
slightly broadened or––more likely––shifted pH optimum
of guanylylation may be the result of a GTP-induced spa-
tial reorientation of amino acid side chains in the vicinity
of the catalytic residue and a concomitant alteration of its
pKa. Alternatively, it may also be explained by the two sub-
strates using different binding sites. These possibilities were
partially addressed in the experiments described in the sub-
sequent sections.
FSBG labeling of nsp9 suggests the presence of a nucleotide
binding site in the NiRAN domain
To verify that the newly discovered nucleotidylation activ-
ity is associated with the NiRAN domain, we first sought
to establish the presence of the expected nucleotide bind-
ing site. To this end, we replaced the substrate in the nu-
cleotidylation assay with the reactive guanosine analog 5′-
(4-fluorosulfonylbenzoyl)guanosine (FSBG) (Supplemen-
tary Figure S4A) (78). Depending on the exact shape of
the nucleotide binding pocket this compound may be suit-
able for binding and reacting with any nucleophile within
the pocket, leaving behind a stable sulfonylbenzoyl tag that
can be readily detected by mass spectrometry. In this way,
residues that are lining the binding site can be identified.
However, because the points of attack of FSBG (sulfonyl
group sulfur) and GTP (-phosphorus) are spatially sep-
arated (∼4A˚, Supplementary Figure S4A and B), these
residues are not necessarily of biological relevance to nu-
cleotidylation but rather are indicative of the local neigh-
borhood of the nucleotidylation reaction.
After analysis of the nucleotidylation reaction mixture
by mass spectrometry, seven modified peptides represent-
ing five distinct nsp9 regions could be assigned: three in (the
vicinity of) the NiRAN domain and two in the RdRp do-
main (Figure 2A and Supplementary Figure S4C). In agree-
ment with previously published results (78), we found only
lysine and tyrosine residues to be modified, as these are
thought to provide the chemically most stable bonds. The
selectivity of the modification was evident from the fact that
only seven lysine and tyrosine residues served as nucleophile
for the reaction. Furthermore, we identified all these pep-
tides in independent experiments using FSBG concentra-
tions ranging from 25 M to 2 mM. Within this range, a
concentration of 100 M was sufficient to detect all seven
peptides. Together this strongly suggests that the reaction
with FSBG only occurred after binding to a specific site(s)
and did not originate from random collisions. Furthermore,
the two modified residues in the EAV RdRp are located in
either a predicted -helix or in a loop not far upstream and
downstream of the AR and ER motifs, respectively, which
are involved in NTP binding in other, better characterized
RdRps. The five modified residues in the EAV NiRAN do-
main are poorly conserved in related arteriviruses and are
located in the vicinity of one of the three major motifs in
either a predicted loop region (1 residue) or a -strand (4
residues). These findings are compatible with the expected
properties of the FSBG modification that may label any
nucleophile within a 4 A˚ distance from the NTP-binding
site(s). We therefore conclude that the peptides identified
in this experiment reflect the presence of a nucleotide bind-
ing site within the RdRp required for RNA synthesis and a
second binding site that is located in the NiRAN domain,
which could serve for nucleotidylation.
Conserved residues of the NiRAN domain but not of the
RdRp domain are required for nucleotidylation activity
In a next step, we examined the importance of conserved
NiRAN residues for the guanylylation and uridylylation ac-
tivities by characterization of alanine substitution mutants
of several residues, including five invariant residues, in re-
combinant EAVnsp9. Notably, none of thesemutations sig-
nificantly reduced expression or stability (data not shown),
indicating that they are most likely compatible with the pro-
tein’s structure. Subsequent characterization demonstrated
that all conserved NiRAN residues that were probed (Fig-
ure 2, Table 1) are important for nucleotidylation activity,
as their replacement with alanine led, with the exception of
S129A, to a drop to below 10% of wild-type protein activ-
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Figure 7. ConservedNiRAN residues are essential for the nucleotidylation
activity. Alanine substitution of conserved NiRAN residues dramatically
decreased the nucleotidylation activity of nsp9. In contrast,mutation of the
non-conserved K106 in the NiRAN domain or the conserved D445 in the
RdRp domain had only a mild effect on activity. Error bars represent the
standard deviation of the mean based on three independent experiments.
ity. In contrast, alanine substitution of a non-conserved N-
terminal residue (K106A) as well as of a conserved residue
in the RdRp domain (D445A of motif AR), which is known
to be essential for the polymerase activity in other RNA
viruses (34), had only a mild effect, preserving at least 75%
of the activity (Figure 7). Thus, we concluded that the iden-
tified sequence motifs in the EAV nsp9 NiRAN domain
are functionally connected to the nucleotidylation activity.
Whether the decrease in activity was due to a loss of affinity,
impairment of catalysis or both remains to be established.
In addition, as the level of remaining activity (again with
exception of the S129A mutant) did not depend on the sub-
strate used, both guanylylation and uridylylation are likely
catalyzed by the same active site.
In contrast to these results, the mutation at position
S129, the only targeted residue that is fully conserved in
arteriviruses but may be replaced by threonine in other
nidoviruses, exhibited a slightly different effect on guany-
lylation and uridylylation. Mutant S129A displayed an in-
termediate activity when using GTP but was almost as de-
ficient as mutants of the nidovirus-wide conserved residues
when UTP was used as substrate (Figure 7). This finding
may indicate that S129 is specifically involved in the hydro-
gen bond network between protein and UTP. Alternatively,
as the covalent binding of the nucleotide occurs via a nucle-
ophilic attack on the -phosphate, this serine may in princi-
ple be suitable to play this role. Although to our knowledge
nucleic acid ligases typically employ lysine and rarely his-
tidine as catalytic residues (88,90), we cannot exclude that
uridylylation occurs via this S129 while guanylylation uti-
lizes another amino acid.
Nucleotidylation occurs via the formation of a phosphoamide
bond
In order to identify which type of amino acid is the cat-
alytic residue involved in nucleotidylation, we probed the
chemical stability of the bond formed between enzyme and
nucleotide. To this end, we subjected the nucleotidylation
product to either a higher or a lower pH for 4 min, while
the protein was heat denatured. The loss of the radioac-
tive label under acidic or alkaline conditions is an indica-
tor for the type of bond that is formed (Figure 8A) (91).
As evident from Figure 8B, the bond between guanosine
phosphate and nsp9 was acid-labile but stable under alka-
line conditions, which is indicative of a phosphoamide bond
originating from either a lysine or histidine. This result was
also confirmed for uridylylation (data not shown), exclud-
ing a direct role for S129 in the attachment of the uridine
phosphate. Since there is no conserved histidine present in
theNiRANdomain,K94 is themost likely candidate within
this domain to fulfill the role of catalytic residue.
Guanosine and uridine phosphates may be attached via dif-
ferent phosphate groups
So far we have demonstrated that guanylylation and uridy-
lylation are essentially equally sensitive to replacement of
NiRAN residues, share the same metal ion requirements,
and both rely on the formation of a phosphoamide bond.
We therefore concluded that there is only one active site re-
sponsible for nucleotidylation, which allows utilization of
both substrates. Interestingly, if this were true, discrimina-
tion of GTP and UTP against ATP and CTP would be
solely based on the presence of an oxygen at C6 of GTP
and C4 of UTP. However, given the pronounced size dif-
ference between UTP and GTP, the positions of both sub-
strates within the binding site are unlikely to be equivalent.
In principle, two binding scenarios are possible. First, the ri-
bose and phosphate moieties of both nucleotides could oc-
cupy the same position within the binding site, for example
by forming hydrogen bonds via the ribose’s 2′ and 3′ hy-
droxyl groups and charge interactions between the protein
and the phosphates. Yet, due to the size difference of the
bases (pyrimidine vs. purine), any additional interactions
between protein and bases would involve different hydrogen
bond networks, potentially involving water molecules in the
case of the smaller UTP. Alternatively, due to stacking in-
teractions between an aromatic residue of the protein and
the bases, uracil and the pyrimidine ring of guanine might
occupy equivalent positions. As this would inevitably lead
to the relative misplacement of the ribose and phosphates
of UTP compared to GTP, the catalytic residue may com-
pensate for the size difference by re-adjusting and attacking
the - instead of the -phosphate of UTP.
To explore the above possibility, nsp9was nucleotidylated
as before and non-bound label was removed by extensive
washing until no residual radioactivity was detected in the
wash buffer. The nucleotide-protein bond was subsequently
broken by lowering of the pH and the released nucleotide
was analyzed by thin layer chromatography. While nsp9 in-
cubated with GTP clearly released significantly more of the
expected guanosine-5’-monophosphate (GMP) in an acidic
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Figure 8. A phosphoamide bond is formed between nsp9 and the guanosine phosphate. (A) Chemical stability of different phosphoamino acid bonds.
Adapted from (91). (B) The protein was labeled with [-32P]GTP and subsequently incubated at pH 8.5 (control) or under acidic or alkaline conditions.
Reaction products were visualized after denaturing SDS-PAGE by Coomassie brilliant blue staining (top panel) and phosphor imaging (bottom panel).
Size markers are depicted on the left in kDa.
Figure 9. GMP is released from labeled EAV nsp9 under acidic conditions.
(A) nsp9 was labeled with [-32P]GTP or [-32P]UTP and was incubated
at pH 8.5 (control) or under acidic or alkaline conditions after removal
of non-incorporated nucleotides. Resulting products were separated with
PEI-cellulose TLC. Solid lines represent the position where samples have
been spotted (bottom) and the running front (top). Dashed lines represent
the respective mobilities of the indicated nucleotides. (B) [-32P]GTP was
incubated under the same conditions as in (A) but omitting nsp9. An nsp9-
containing sample treated with HCl served as positive control.
environment than under alkaline conditions, the results af-
ter uridylylation were not as conclusive. Although also in
this case the monophosphate was released after HCl treat-
ment, the intensity did not match that of GMP and a sec-
ond product was present in higher quantities (Figure 9A).
This may indicate that uridine-5’-monophosphate (UMP)
is either further hydrolyzed under these conditions or that
in fact a UMP–protein adduct is only the minor product af-
ter uridylylation. Therefore, it remains unclear whether the
binding of UTP indeed forces an attack of the -phosphate.
To exclude that the observed GMP release is caused by the
treatment with HCl, control samples lacking nsp9 were also
investigated. As expected this did not result in a product
with equivalent mobility to GMP (Figure 9B).
NiRANnucleotidylation is essential for EAVandSARS-CoV
replication in cell culture
To establish the importance of the NiRAN domain for
nidoviral replication, we used reverse genetics to engineer
both EAV and SARS-CoV mutants in which conserved
NiRAN residues were substituted with alanine. Follow-
ing transfection of in vitro-transcribed full-length RNA
into permissive cells, viral protein expression and progeny
release were monitored (Table 1). As expected for such
conserved residues, most alanine substitutions were either
lethal for the virus or resulted in a severely crippled virus
that reverted, thus confirming the essential role of the nu-
cleotidylation activity during the viral replication cycle.
Similarly, also replacement of a conserved aspartate in mo-
tif A of the downstream RdRp domain, which is known to
be required for the activity of polymerases in other (+)RNA
viruses (34), was tolerated in neither EAV nor SARS-CoV.
Notable exceptions to this general pattern, in addition to the
replacements of non-conserved lysine residues included as
controls, were the T123A and F219A mutations in SARS-
CoV nsp12. These mutations were stably maintained al-
though they produced a mixed plaque phenotype compris-
ing wild-type-sized and smaller plaques, with F219A also
demonstrating a markedly lower progeny titer (at least two
logs reduced) than the wild-type control (Figure 10). The
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Table 1. Reverse genetics analysis of EAV nsp9 and SARS-CoV nsp12 mutants
Virus Motif Mutant Mutation
Virus titers (PFU/ml
at 16–18 h p.t.)
nsp9/nsp12 sequence of
P1 virusa
wt 1·107, 2·108 n.d.
AN K94A AAA→GCA <20, <20 Reversion
Non-conserved K106A AAA→GCA 3·105, 2·106 GCA
BN R124A CGU→GCU <20, <20 Reversion
EAV BN S129A UCG→GCG 1·104, 5·103 Reversion
BN D132A GAU→GCU 3·104, 6·103 Reversion
CN D165A GAU→GCU 3·103, 1·104 Reversion
CN F166A UUU→GCU <20, <20 n.a.
AR D445A GAC→GCC <20, 1·104 Reversion
wt 4·106, 3·105 n.d.
AN K73A AAG→GCC <20, <20 n.a.
Non-conserved K103A AAG→GCA <20, <20 GCA
BN R116A CGU→GCU <20, <20 n.a.
SARS-CoV BN T123A ACA→GCU 1·105, 4·105 GCU
BN D126A GAU→GCG <20, <20 n.a.
CN D218A GAU→GCU <20, <20 n.a.
CN F219A UUC→GCG 2·104, 8·102 GCG
AR D618A GAU→GCG <20, <20 n.a.
aVirus-containing supernatants were collected at 72 h p.t. and subsequently used for re-infection of fresh BHK-21 (EAV) or Vero-E6 (SARS-CoV) cells.
Total RNA was isolated after appearance of CPE and nsp9/nsp12 coding regions were sequenced. All results were confirmed in a second independent
experiment. n.d., not done; n.a., not applicable (non-viable phenotype).
Figure 10. Plaque phenotypes of viable SARS-CoV NiRAN mutants.
Progeny virus harvested at 3 days post transfection was used for plaque
assays (see ‘Materials and Methods’ section) on Vero-E6 cell monolay-
ers, which were fixed and stained after 3 days to visualize virus-induced
plaques.
reason for this differential behavior of these two SARS-CoV
mutants in comparison to those of EAV is unclear at the
moment.
DISCUSSION
NiRAN is the first enzymatic genetic marker of the order
Nidovirales
The NiRAN domain described in this study is the fourth
ORF1b-encoded enzyme involved in RNA-dependent pro-
cesses identified in arteriviruses and the seventh in coron-
aviruses. As in most prior studies of nidoviral replicative
proteins, this identification was initiated by comparative ge-
nomics analysis. Unlike all other nidovirus enzymes, how-
ever, NiRAN was found to have no appreciable sequence
similarity with proteins outside the order Nidovirales. Even
the similarity between the arteriviral NiRAN and that of
other nidoviruses was found to be marginal. These results
suggested that NiRAN either is a unique enzyme specific
to nidoviruses or has diverged from its paralogs beyond
recognition, i. e. to an extent that cannot be ascertain by
even the most powerful HMM-based tools currently avail-
able. The latter possibility is not merely hypothetical given
that five out of the seven amino acid residues that are evolu-
tionary invariant in the NiRAN domain belong to the most
common residues found in proteins. We expect this uncer-
tainty to be resolved in the future when the sampling of
nidoviruses will be expanded, sequence profile techniques
will be further advanced, and tertiary structures of the pro-
teins analyzed in this study may become available.
Besides technical challenges in the identification of Ni-
RAN, this domain also stands out for its properties that
are indicative of an unknown but critical role in nidovirus
replication (see below).NiRAN is the onlyORF1b-encoded
domain that is located upstream of the RdRp and resides
within the same non-structural protein. This implies that
NiRANmay influence the folding of the downstreamRdRp
domain. It would be reasonable to expect cross-talk be-
tween these domains, potentially coupling the reactions and
processes they catalyze. Thus, NiRAN is a prime candidate
regulator and/or co-factor of the RdRp, a property that
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should be taken into account in future experiments aim-
ing at the characterization of the RdRp or reconstitution
of RTC activity in vitro.
The exclusive conservation of NiRAN in nidoviruses is
indicative of its acquisition by a nidovirus ancestor be-
fore the currently known nidovirus families diverged. This
makes the domain a genetic marker of this virus order, only
the second after the previously identified ZBD and the first
with enzymatic activity. It may not be a coincidence that
each of these markers is associated with a key enzyme in
(+) RNA virus replication, RdRp and HEL1, respectively.
TheHEL1-modulating role of the ZBD and its involvement
in all major processes of the nidovirus replicative cycle have
been documented (reviewed in (20)). Similar studies could
be performed to probe the function(s) of NiRAN.
Possible functions of conserved NiRAN residues
Wehere demonstrated thatNiRAN is essential for EAV and
SARS-CoV replication in cell culture by testing mutants in
which conserved residues had been replaced. The mutated
viruses were either crippled (and in most cases reverted to
wt) or dead, depending on the targeted residue and the virus
studied. Importantly the magnitude of the observed effect
paralleled that caused by replacement of an RdRp active
site residue in the same virus. This parallel is most notable
because of the much higher divergence of the NiRAN se-
quence compared to the RdRp. Also, the significance of Ni-
RAN for virus replication must be different from that of
NendoU, the only other ORF1b-encoded enzyme that has
been probed extensively by mutagenesis in reverse genetics
in both corona- and arteriviruses (25,50,92). Two of those
studies revealed that EAV andmouse hepatitis virus (MHV)
NendoU mutants with replacements in the active site were
stable and in the latter case even displayed similar plaque
phenotypes as the wild-type virus while being only slightly
delayed in growth (50,92).
In our biochemical assays of the nidovirus RdRp sub-
unit (40,42,93), we detected the new nucleotidylation ac-
tivity that was associated with the NiRAN of EAV nsp9,
as demonstrated by mass spectrometry analysis (Figure 2A
and Supplementary Figure S4) and the importance of con-
served NiRAN residues for this activity (Figure 7). Nu-
cleotidylation was most pronounced with UTP as substrate
but was also observed with GTP (Figure 5A). Despite their
size difference, both substrates appeared to be utilized by
the same NiRAN binding site since uridylylation as well as
guanylylation depended on the same conserved residues. To
our knowledge such dual specificity has never been reported
for a protein of anRNAvirus and (likely) a host. Our results
strongly suggested the nucleotidylated residue to be either
a lysine or a histidine (Figure 8) located in the N-terminal
part of nsp9. Since NiRAN lacks a conserved histidine, the
conserved lysine of motif A (K94 in EAV nsp9) is the most
likely target for nucleotidylation.
Given the non-radioactive endogenousNTP pool present
in E. coli, these results imply that during its expression a
part of the recombinant nsp9 may have already been con-
verted to the described nucleoside adducts. Consequently,
only the free nsp9 must have been available for nucleotidy-
lation by its NiRAN domain using radioactive GTP/UTP.
The nucleotidylated fraction of the total protein pool de-
pends on many factors, including the adduct’s stability, and
remains unknown. However, this uncertainty does not un-
dermine the validity of the established nucleotidylation ac-
tivity of nsp9, given the specificity and selectivity docu-
mented here, which were determined using different tech-
niques and various controls to arrive at a consistent set of
properties of the enzyme. Combined, the results of our bio-
chemical and bioinformatics analyses assigned nucleotidy-
lation activity to the NiRAN domain beyond a reasonable
doubt. To rationalize the protein’s ability to bind nucleoside
phosphates covalently, future studies may focus on the role
of protein–nucleoside adducts as reaction intermediates for
possible downstream processes, three of which are discussed
below.
Next to K94 and/or conserved R124 of motif BN, which
may mediate NTP binding via interactions with the nega-
tively charged phosphates, a third conserved residue which
may contribute to NTP binding is the motif CN phenylala-
nine (F166 in EAV). Since phenylalanine would most likely
interact with the nucleotide substrate by base stacking, its
contribution in terms of binding energy would be one order
of magnitude lower than that of electrostatic interactions
of lysine/arginine with the phosphates (94). Based solely on
this consideration, F166 could be expected to be of ‘lesser’
importance than the basic residues. However, this was ap-
parently not the case since the replacement of the aromatic
residue with alanine was lethal for EAV while substitution
of either of the basic residues led to a low level of replica-
tion that eventually facilitated reversion (Table 1). All these
substitutions require two nucleotide point mutations to re-
vert back to wild-type, which should be an extremely rare
event during a single round of replication. Consequently,
the non-viable phenotype of the F166A mutant may hint
at a lower tolerance of single-nucleotide partial revertants
(F166V or F166S) in comparison to those originating from
K94A (K94T or K94E) and R124A (R124P or R124G).
Alternatively, the observed non-viable F166A phenotype
may be explained by a vital interaction between NiRAN
and RdRp or other proteins involving F166. In contrast to
EAV, the homologous residue in SARS-CoV nsp12, F219,
appeared to be less essential since its replacement merely
reduced progeny titers and altered the plaque phenotype,
while the nucleotide changes were maintained. At present,
the exact reason for this difference betweenEAVand SARS-
CoV is unclear, but it suggests that the role and/or regula-
tion of this conserved phenylalanine may have evolved in
these distantly related nidoviruses, whose NiRAN domains
are of strikingly different sizes; such evolution has parallels
in other enzymes (95).
Since neither binding of phosphates nor base stacking
would enable the enzyme to discriminate between the four
bases, it is likely that some of the conserved residues are in-
volved in the formation of a hydrogen bond network that is
specific for GTP or UTP. The conserved serine/threonine
of motif BN could be a candidate as substitution of this
serine in EAV nsp9 (S129) was the only mutation that
had a differential effect on guanylylation and uridylyla-
tion (Figure 7). Finally, in agreement with observations for
other nucleotidylate-forming enzymes (96–98), also nsp9
nucleotidylation is metal-dependent (Figure 5B), poten-
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tially due to an important role for metal ions in coordi-
nation of the triphosphate or charge neutralization of the
pyrophosphate leaving group. In our in vitro system it was
Mn2+ rather than the most common divalent cation Mg2+
that supported nucleotidylation activity when tested over a
wide concentration range. We propose that at least one of
the three acidic conserved residues (E100, D132 and D165
in EAVnsp9) is directly involved in the binding of this essen-
tial manganese ion(s). Since the concentration of this cation
in cells is lower than that required to observe nucleotidyla-
tion in vitro, we cannot exclude the possibility that another
co-factor or substrate modulates this property of the en-
zyme in vivo, and/or that another metal ion is used.
Possible roles of nucleotidylation in the context of viral repli-
cation
The identification of the nucleotidylation activity raises the
question which role it may play in the nidovirus replicative
cycle. In the discussion that follows, we will consider the
pros and cons of the involvement of NiRAN’s nucleotidy-
lation activity in three previously described functions that
are not involved in energy-dependent metabolic processes:
nucleic acid ligation, mRNA capping and protein-primed
RNA synthesis.
Ligase function
We initially consideredNiRAN to be a non-canonical ATP-
dependent RNA ligase. It was reasoned that, in the con-
text of nidovirus replication, such an activity could be the
functional complement of the NendoU endoribonuclease
(7). Moreover, at that time both enzymes were considered
to have been conserved across all taxa during evolution of
the nidovirus lineage. However, it recently became clear that
NendoU is conserved only in nidoviruses infecting verte-
brate hosts. Consequently, our original hypothesis would
not explain why this putative ligase would be conserved
in roni- and mesoniviruses, which do not encode the en-
doribonuclease. Another complication regarding that orig-
inal hypothesis has emerged from the present study, which
identified NiRAN as being UTP/GTP-specific. Although
the hydrolysis of all NTPs results in the release of the
same amount of energy, ATP-dependent RNA ligases dom-
inate the ligase family. It would therefore be surprising,
if nidoviruses encoded a ligase that strongly discriminates
against ATP. To our knowledge the GTP-specific tRNA-
splicing ligase RtcB is the only currently known example
of a protein involved in nucleic acid strand joining exhibit-
ing this kind of substrate specificity (90). Furthermore, thus
far no substrates that would require a ligase function were
identified in nidovirus replication, which however remains
poorly characterized in general.
5′ end cap guanylyltransferase function
Besides RNA ligases, also guanylyltransferases (GTases)
employ a very similar mechanism of nucleotidylation and
are used to permanently modify the 5′ end of RNA with
the bound GMP in a process called RNA capping (re-
viewed in (99)). Intriguingly, three of the four enzyme activ-
ities required for cap formation and modification, namely
an RNA-triphosphatase and two methyltransferases, have
been identified in coronaviruses (44,100), with the miss-
ing activity being the GTase. Furthermore, recent char-
acterization of EAV nsp10 in our lab (unpublished data)
showed that it resembles its coronavirus homolog in terms
of possessing RNA-triphosphatase activity, which is re-
quired prior to GTase activity in the conventional cap-
ping pathway. In line with these findings, experimental ev-
idence supporting the presence of a cap structure on ge-
nomic RNA was reported for three very distantly related
viruses of the Nidovirales order, namely for MHV (Coro-
navirinae) (101), Equine torovirus (Torovirinae) (102) and
Simian hemorrhagic fever virus (Arteriviridae) (103). Im-
portantly, the known GTases of (+) RNA viruses, fla-
vivirus NS5 (104), alphavirus nsP1 and orthologous pro-
teins (97,105), do neither share conserved features nor do
they resemble host GTases. Thus, the possibility of NiRAN
being a cap-synthesizing GTase could be reconciled with
our current knowledge of the structural and sequence diver-
sity of this class of enzymes. This cannot be said, however,
about NiRAN’s substrate preference for UTP over GTP,
which has not been reported for GTases mediating cap for-
mation.
Protein-priming function
If UTP binding by NiRAN reflects a genuine property of
the enzyme, another mechanism that might utilize its nu-
cleotidylation activity may be protein-primed RNA synthe-
sis. This strategy is used by many viruses including the large
group of picornavirus-like viruses, which notably have evo-
lutionary affinity to nidoviruses (35,36). In these viruses, a
nucleotide is covalently attached to a protein that is com-
monly known as VPg (viral protein genome-linked), which
may then be extended to a dinucleotide. This dinucleotide
is subsequently base-paired to the 3′ end of the viral RNA
where it serves as primer for the synthesis of the com-
plementary RNA strand (106). Interestingly, the first nu-
cleotide of the EAV genome is a G while the 3′ end is
equipped with a poly(A) tail. Thus, the dual specificity of
nsp9 for GTP and UTP would be compatible with the dif-
ferent requirements for the initiation of the synthesis of ge-
nomic and subgenomic RNAs of positive and negative po-
larity, respectively. To which extent this property is con-
served across nidoviruses remains to be established.
While considering this mechanism, it is instructive to
take into account observations that distinguish nidoviruses
from VPg-utilizing viruses. First, to our knowledge, all cur-
rently described nucleotide-VPg bonds are realized via the
hydroxyl group of either a tyrosine or a serine/threonine
(107–111), while NiRAN most likely uses the invariant ly-
sine residue (Figure 8). This problem could be resolved if
NiRAN assumes the role of the RdRp of VPg-encoding
viruses and transfers the bound nucleotide to another pro-
tein that subsequently serves as VPg. Second, at least for
coronaviruses, the VPg-based mechanism would not be
compatible with the previously proposed primase-based
mechanism (112) for the initiation of RNA synthesis. How-
ever, the latter mechanism remains tentative since it assigns
primase activity to a protein complex that, according to a
recent study (84), may merely be a processivity co-factor for
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the nsp12 RdRp. Finally, as mentioned before, the mRNAs
of several nidoviruses were concluded to be capped at their
5′ end, a modification that is not observed in known VPg-
utilizing viruses. To use both VPg priming and capping, it
would be necessary to actively or passively remove the at-
tached protein in order to allow mRNA capping to com-
mence. This sequence of events would constitute a novel,
and perhaps unlikely, variant of the capping pathway, as the
RNA’s 5′ end would not be di- or triphosphorylated after
VPg removal, a requirement for entering any of the known
viral capping pathways (99). Thus, if NiRANwould be part
of a VPg-utilizing mechanism, this might differ consider-
ably from those currently described and could possibly also
vary among nidoviruses.
In view of the considerations outlined for each of the
three possible scenarios employing nucleotidylation activ-
ity, it is evident that presently none of these can be recon-
ciled with the evolutionary, structural and functional char-
acteristics of NiRAN described in this study without ad-
ditional assumptions. This may reflect yet-to-be revealed
specifics of the nidovirus RTC and its unparalleled com-
plexity.
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Supplementary Data are available at NAR Online.
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